IPG Photonics Corporation (NASDAQ:IPGP) Short Interest Update

IPG Photonics Corporation (NASDAQ:IPGP) was the recipient of a large decline in short interest during the month of March. As of March 13th, there was short interest totaling 1,840,528 shares, a decline of 15.0% from the February 26th total of 2,165,139 shares. Based on an average daily trading volume, of 558,241 shares, the days-to-cover ratio is currently 3.3 days. Currently, 7.2% of the company’s stock are sold short.

IPG Photonics Stock Up 2.1%

Shares of IPGP stock opened at $116.98 on Wednesday. The company has a market cap of $4.94 billion, a P/E ratio of 156.96, a PEG ratio of 2.64 and a beta of 0.95. The business has a 50 day moving average of $116.95 and a two-hundred day moving average of $93.47. IPG Photonics has a 52 week low of $48.59 and a 52 week high of $155.82.

IPG Photonics (NASDAQ:IPGP) last released its quarterly earnings data on Thursday, February 12th. The semiconductor company reported $0.46 earnings per share for the quarter, topping analysts’ consensus estimates of $0.25 by $0.21. The business had revenue of $274.47 million for the quarter, compared to analysts’ expectations of $249.58 million. IPG Photonics had a net margin of 3.10% and a return on equity of 2.89%. The company’s revenue for the quarter was up 17.2% compared to the same quarter last year. During the same quarter last year, the company earned $0.18 EPS. IPG Photonics has set its Q1 2026 guidance at 0.100-0.400 EPS. Analysts expect that IPG Photonics will post 1.54 EPS for the current fiscal year.

Insider Buying and Selling at IPG Photonics

In other IPG Photonics news, Director Eric Meurice sold 750 shares of the stock in a transaction that occurred on Monday, February 2nd. The stock was sold at an average price of $95.00, for a total transaction of $71,250.00. Following the transaction, the director owned 22,803 shares in the company, valued at approximately $2,166,285. This represents a 3.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Mary E. Buttarazzi sold 500 shares of the business’s stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $116.22, for a total transaction of $58,110.00. Following the transaction, the chief accounting officer owned 4,749 shares in the company, valued at $551,928.78. The trade was a 9.53% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 134,617 shares of company stock worth $10,636,883. Corporate insiders own 39.50% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in IPGP. Versant Capital Management Inc lifted its stake in IPG Photonics by 51.1% in the third quarter. Versant Capital Management Inc now owns 343 shares of the semiconductor company’s stock valued at $27,000 after acquiring an additional 116 shares during the last quarter. Assetmark Inc. increased its stake in shares of IPG Photonics by 6.8% in the fourth quarter. Assetmark Inc. now owns 1,820 shares of the semiconductor company’s stock worth $130,000 after purchasing an additional 116 shares during the period. Deutsche Bank AG raised its stake in IPG Photonics by 6.1% during the 4th quarter. Deutsche Bank AG now owns 2,214 shares of the semiconductor company’s stock valued at $159,000 after purchasing an additional 128 shares during the last quarter. Allworth Financial LP raised its stake in shares of IPG Photonics by 10.2% in the 3rd quarter. Allworth Financial LP now owns 1,449 shares of the semiconductor company’s stock valued at $115,000 after buying an additional 134 shares in the last quarter. Finally, Comerica Bank boosted its position in shares of IPG Photonics by 0.9% during the 4th quarter. Comerica Bank now owns 15,105 shares of the semiconductor company’s stock valued at $1,082,000 after acquiring an additional 135 shares in the last quarter. 93.79% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. Weiss Ratings restated a “sell (d+)” rating on shares of IPG Photonics in a research note on Friday. Roth Mkm raised their price target on IPG Photonics from $105.00 to $110.00 and gave the company a “buy” rating in a research report on Tuesday, February 3rd. Zacks Research upgraded shares of IPG Photonics from a “hold” rating to a “strong-buy” rating in a report on Thursday, January 15th. Stifel Nicolaus lifted their target price on shares of IPG Photonics from $92.00 to $165.00 and gave the stock a “buy” rating in a research note on Friday, February 13th. Finally, Raymond James Financial lowered IPG Photonics from a “strong-buy” rating to an “outperform” rating and increased their price target for the stock from $97.00 to $180.00 in a research note on Friday, February 13th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $131.40.

About IPG Photonics

IPG Photonics Corporation is a global leader in the design and manufacture of high-performance fiber lasers and amplifiers used in industrial, medical, scientific, and telecommunications applications. The company’s core products include ytterbium and erbium fiber lasers, diode lasers, and fiber amplifiers that deliver high power and efficiency for precision cutting, welding, marking, and engraving. IPG’s systems are engineered to optimize process speed, reliability, and energy consumption, making them a preferred choice for advanced manufacturing environments.

In addition to stand-alone laser sources, IPG offers turnkey laser systems and integrated solutions tailored to sectors such as automotive, electronics, aerospace, additive manufacturing, and life sciences.